Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.

Considering the important advances in treating specific types of systemic amyloidoses, unequivocal typing of amyloid deposits is now essential. Subcutaneous abdominal fat aspiration is the easiest, most common diagnostic procedure. We developed a novel, automated approach, based on Multidimensional Protein Identification Technology, for typing amyloidosis. Fat aspirates were obtained from patients with the most common systemic amyloidoses (ALλ, ALκ, transthyretin, and reactive amyloidosis), with Congo red score more than or equal to 3+, and nonaffected controls. Peptides from extracted and digested proteins were analyzed by Multidimensional Protein Identification Technology. On semiquantitative differential analysis (patients vs controls) of mass spectrometry data, specific proteins up-represented in patients were identified and used as deposit biomarkers. An algorithm was developed to classify patients according to type and abundance of amyloidogenic proteins in samples; in all cases, proteomic characterization was concordant with fibril identification by immunoelectron microscopy and consistent with clinical presentation. Our approach allows reliable amyloid classification using readily available fat aspirates.

[1]  Michaela Scigelova,et al.  Multidimensional protein identification technology for clinical proteomic analysis , 2009, Clinical chemistry and laboratory medicine.

[2]  M. Eulitz,et al.  Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. , 2001, Biochemical and biophysical research communications.

[3]  W. Szarek,et al.  The FASEB Journal express article 10.1096/fj.03-1436fje. Published online September 2, 2004. , 2022 .

[4]  D. Seldin,et al.  Amyloidosis: pathogenesis and new therapeutic options. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. R. Bergen,et al.  Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. , 2011, Archives of neurology.

[6]  Betül Çelebi,et al.  Proteome analysis of rat bone marrow mesenchymal stem cell differentiation. , 2010, Journal of proteome research.

[7]  David H Perlman,et al.  Amyloidogenic and Associated Proteins in Systemic Amyloidosis Proteome of Adipose Tissue*S , 2008, Molecular & Cellular Proteomics.

[8]  Pierluigi Mauri,et al.  Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach. , 2006, Biochimie.

[9]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[10]  P. Westermark,et al.  Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis. , 2006, Acta histochemica.

[11]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[12]  Pierluigi Mauri,et al.  A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli. , 2008, Methods in enzymology.

[13]  T. Rademacher,et al.  Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Wisniewski,et al.  Potential role of apolipoprotein-E in fibrillogenesis. , 1994, The American journal of pathology.

[15]  It Istituto Superiore di Sanit,et al.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004 , 2005 .

[16]  G. Merlini,et al.  Clinical aspects of systemic amyloid diseases. , 2005, Biochimica et biophysica acta.

[17]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[18]  D. Seldin,et al.  Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy. , 2011, The American journal of pathology.

[19]  Tabiwang N. Arrey,et al.  Identification of novel human adipocyte secreted proteins by using SGBS cells. , 2010, Journal of proteome research.

[20]  R. Falk,et al.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.

[21]  P. Arner,et al.  Changes in Adipose Tissue Gene Expression with Energy-restricted Diets in Obese Women , 2022 .

[22]  P. Westermark,et al.  Unreliability of immunohistochemistry for typing amyloid deposits. , 2008, Archives of pathology & laboratory medicine.

[23]  A. Godzik,et al.  A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins , 2010, BMC Genomics.

[24]  D. Booth,et al.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. , 2002, The New England journal of medicine.

[25]  E. Arbustini,et al.  Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[26]  B. Hazenberg,et al.  Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis , 2007, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[27]  M. Picken,et al.  The burden of "sticky" amyloid: typing challenges. , 2007, Archives of pathology & laboratory medicine.